ClinicalTrials.gg

Drug class

Hypnotics and Sedatives clinical trials

A class of medicines: the studies that test any of its 28 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
2,840
open now
431
in phase 3
381
first study started
1993

Keep track of what changes. Save the hypnotics and sedatives studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Amobarbital
2
Lormetazepam
2
Indiplon
2
Paraldehyde
1
Flurazepam
1
Nitrazepam
1
Chlormethiazole
1

Studies by the year they started

2,832 studies that test it; most in 2024 (196); 2 more planned to start later

Studies that test Hypnotics and Sedatives, by start year
YearStudies
19931
19951
19962
19971
19991
20007
20015
20024
200317
200434
200545
200664
200757
200876
200976
201084
201194
201298
201397
2014157
2015141
2016154
2017177
2018117
2019144
2020132
2021158
2022191
2023173
2024196
2025172
2026156

By phase

A phase 1/2 study counts in both.

Early Phase 1
66
Phase 1
438
Phase 2
335
Phase 3
381
Phase 4
925
No phase
852

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 422 · Other 2,418

Assiut University (115) · Ain Shams University (65) · Yonsei University (58) · Tanta University (55) · Cairo University (41) · Seoul National University Hospital (39) · Peking University First Hospital (37) · Boehringer Ingelheim (30)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 2,840

See all 2,840 studies that test one of the hypnotics and sedatives →

Codes

What other systems call Hypnotics and Sedatives · ClinicalTrials.gg INT007641

  • MeSH (NLM) D006993Hypnotics and SedativesOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.